Tegomil fumarate

富马酸替格米酯

Report date: 2026/02/05 16:40:02
NME

Base Information

Drug NameTegomil fumarate
Drug Alias NameRiulvy
ClassificationSmall molecules
Mechanisms of ActionNuclear factor erythroid 2-related factor 2 activators
TargetsNuclear factor erythroid 2-related factor 2
Therapy Area/IndicationsMultiple Sclerosis, Relapsing-Remitting
Global Approved IndicationsMultiple Sclerosis, Relapsing-Remitting
Approved Indications in ChinaN/A
Original Approved Country/TerritoryEU
Original Approved Date2025/07/28
Country/TerritoryEU
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesNeuraxpharm Pharmaceuticals Sl
China Registration ClassN/A

Develop Information

Inactive CompaniesN/A
Active IndicationsMultiple Sclerosis, Relapsing-Remitting
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A